Andorra: Health spending per capita

* indicates monthly or quarterly data series

Health spending per capita

 Latest value 3,336.92
 Year 2020
 Measure U.S. dollars
 Data availability 2000 - 2020
 Average 2,655.33
 Min - Max 1,286.86 - 3,956.99
 Source The World Bank
For that indicator, we provide data for Andorra from 2000 to 2020. The average value for Andorra during that period was 2655.33 U.S. dollars with a minimum of 1286.86 U.S. dollars in 2000 and a maximum of 3956.99 U.S. dollars in 2011. The latest value from 2020 is 3336.92 U.S. dollars. For comparison, the world average in 2020 based on 179 countries is 1229.55 U.S. dollars. See the global rankings for that indicator or use the country comparator to compare trends over time.
Select indicator
* indicates monthly or quarterly data series

Recent values chart
Andorra - Health spending per capita - Recent values chart

Historical chart
Andorra - Health spending per capita - historical chart - 2000-2020

Definition: Current expenditures on health per capita in current US dollars. Estimates of current health expenditures include healthcare goods and services consumed during each year.

Selected articles from our guide:

What factors determine the exchange rates

International lending and sovereign debt

Are trade deficits bad for the economy?

The unholy trinity of international finance

Most commonly used measures of corruption

All articles

 Related indicators Latest value Reference Measure
 Health spending per capita 3,336.92 2020 U.S. dollars
 Health spending as percent of GDP 9.05 2020 percent
 Birth rate 7.00 2019 births per 1000 people
 Death rate 3.90 2019 deaths per 1000 people
 Fertility rate 1.27 2010 births per woman
 Tuberculosis 5.80 2022 cases per 100,000 people
 Diabetes prevalence 9.70 2021 percent
 Prevalence of anemia among children 14.10 2019 percent
 DPT immunization rate 98 2022 percent
 Hepatitis B immunization rate 96 2022 percent
 Measles immunization rate 98 2022 percent
 Traffic accident deaths 7.60 2013 deaths per 100,000 people
This site uses cookies.
Learn more here